Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-054686

President and CEO sold 3,576 shares at $1.13 ($4,041)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-06 Sale : show line 1 in the form −3,576 $1.13 $4,041 1,153,697 D
Open-market sales · 3,576 sh · avg $1.13 · $4,041
Loading xslF345X05/ownership.xml…